For a patient in alcohol‑use‑disorder rehabilitation with major depressive disorder, generalized anxiety disorder, and PTSD who is currently taking sertraline 100 mg daily, trazodone 100 mg as needed for sleep, and hydroxyzine (Vistaril) 50 mg every six hours, is this medication plan appropriate?

This medication plan has significant concerns and requires modification

The current regimen is problematic primarily due to the scheduled hydroxyzine dosing (50 mg q6hrs = 200 mg/day), which exceeds evidence-based recommendations and poses unnecessary sedation risk in a patient already on trazodone. The sertraline 100 mg is appropriate for MDD, GAD, and PTSD 1, 2, but the adjunctive medications need optimization.

Critical Issues with Current Plan

Hydroxyzine Dosing is Excessive

• Hydroxyzine 50 mg every 6 hours totals 200 mg/day—this is excessive for anxiety management 3
• Evidence supports hydroxyzine for GAD, but at much lower doses and PRN use, not scheduled dosing 3
• The combination of scheduled hydroxyzine plus trazodone creates redundant sedation and increases fall risk, particularly problematic during early alcohol rehabilitation when coordination may already be impaired
• Hydroxyzine should be reduced to 25-50 mg PRN (maximum 100 mg/day) for breakthrough anxiety, not standing q6hr dosing

Trazodone Use is Appropriate but Requires Monitoring

• Trazodone 100 mg PRN for sleep is reasonable and has specific evidence in PTSD-related insomnia 4, 5, 6
• In one study, 72% of PTSD patients found trazodone helpful for nightmares (reducing frequency from 3.3 to 1.3 nights/week), with effective doses typically 50-200 mg 6
• Critical caveat: 12% incidence of priapism was reported—you must counsel the patient about this risk and instruct immediate reporting of prolonged erections 6
• Other common side effects include daytime sedation and dizziness (60% of patients) 6

Sertraline is the Correct Foundation

• Sertraline 100 mg is FDA-approved for MDD, GAD, and PTSD 2
• For PTSD specifically, the 2023 VA/DoD guidelines give a STRONG recommendation for sertraline or paroxetine as first-line pharmacotherapy 1
• The dose range is 50-200 mg/day; current 100 mg dose is appropriate, though may need titration to 150-200 mg if inadequate response after 4-6 weeks 2
• Important for AUD context: Evidence for sertraline in comorbid alcohol dependence with depression or PTSD is mixed 7, 8, 9
  • One large trial (328 patients) showed no benefit over placebo for co-occurring MDD and alcohol dependence 7
  • Another trial (94 patients) showed differential response based on severity—those with less severe alcohol dependence and early-onset PTSD responded better to sertraline 8
  • SSRIs should be used cautiously in actively drinking patients as they may paradoxically increase consumption in some individuals 10

Recommended Medication Plan

Modify the regimen as follows:

1. Continue sertraline 100 mg daily (morning dosing to minimize insomnia)

   • Monitor for 4-6 weeks; if inadequate response, increase to 150 mg, then 200 mg maximum 2
   • Reassess at 9-12 months minimum before considering discontinuation 2

2. Change hydroxyzine to PRN dosing: 25-50 mg PRN for breakthrough anxiety (maximum 100 mg/day)

   • Discontinue the standing q6hr schedule
   • Use only when needed for acute anxiety episodes
   • This reduces sedation burden and fall risk

3. Continue trazodone 100 mg PRN at bedtime for insomnia

   • Counsel explicitly about priapism risk (12% incidence)—instruct to seek emergency care for erections lasting >4 hours 6
   • Can increase to 150-200 mg if 100 mg insufficient for sleep 6
   • Monitor for daytime sedation

4. Consider adding gabapentin 300-900 mg/day if anxiety remains inadequately controlled

   • Gabapentin has evidence for both anxiety and alcohol use disorder 10
   • Start 300 mg at bedtime, titrate as needed
   • Provides non-sedating anxiolysis without benzodiazepine risks

Critical Monitoring Points

What NOT to Use

• Avoid benzodiazepines entirely—the 2023 VA/DoD PTSD guidelines give a STRONG recommendation AGAINST benzodiazepines in PTSD 1
• Benzodiazepines worsen PTSD outcomes, increase addiction risk, and complicate alcohol recovery
• Do not use cannabis or cannabis-derived products (also strongly recommended against) 1

Alcohol Use Disorder Considerations

• The evidence does NOT support that sertraline will improve drinking outcomes 7, 8, 9
• Ensure patient is engaged in evidence-based psychotherapy (CBT) plus pharmacotherapy for AUD (naltrexone, acamprosate, or disulfiram) 11
• Combined CBT + pharmacotherapy for AUD is superior to usual care alone 11
• Monitor for increased alcohol consumption if patient is still drinking while on sertraline 10

Timeline Expectations

• Sertraline: 4-6 weeks for full anxiolytic/antidepressant effect 2
• Trazodone: Immediate effect on sleep, 6-12 weeks for nightmare reduction 5, 6
• Hydroxyzine: Immediate anxiolytic effect when used PRN 3

Gender Considerations

• If patient is female, note that women have higher stress/anxiety levels and may be more vulnerable to maintaining alcohol consumption 10
• Women may require more intensive anxiety management during alcohol rehabilitation

Common Pitfalls to Avoid

1. Do not continue excessive scheduled hydroxyzine—this creates unnecessary sedation and doesn't align with evidence-based dosing
2. Do not forget priapism counseling with trazodone—this is a medical emergency
3. Do not expect sertraline to treat the alcohol use disorder—it treats the psychiatric comorbidities but requires separate AUD-specific interventions
4. Do not add benzodiazepines for anxiety—this is contraindicated in PTSD and complicates addiction recovery 1
5. Do not discontinue sertraline prematurely—requires 9-12 months minimum after response 2